4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tenaya Therapeutics, Inc. (TNYA) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 70 employees. Its market capitalization is roughly $184 million. In the fiscal year ended 2025-12-31, TNYA reported $0M in revenue and ($91M) in net income.
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
Interactive charts & full statements → Open the TNYA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($93M) | ($116M) | ($131M) | ($126M) |
| Net Income | ($91M) | ($111M) | ($124M) | ($124M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($20M) | ($21M) | ($21M) | ($24M) | ($28M) | — |
| Net Income | ($19M) | ($20M) | ($20M) | ($23M) | ($27M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $147M | $120M | $170M | $279M | — |
| Total Liabilities | $24M | $27M | $31M | $36M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TNYA viewer.
About TickerBase · Data methodology & sources